NCT01988012View on ClinicalTrials.gov

A Study of the Efficacy and Safety of Tocilizumab in Adults With Rheumatoid Arthritis.

PHASE3CompletedINTERVENTIONAL

Enrollment

100

Participants

Timeline

Start Date

January 31, 2014

Primary Completion Date

July 31, 2015

Study Completion Date

July 31, 2015

Conditions

Rheumatoid Arthritis

Interventions

BIOLOGICAL

tocilizumab

162 milligram (mg) administered subcutaneously once weekly for 24 weeks

Trial Locations (13)

34362

Haifa

44281

Kfar Saba

91240

Jerusalem

3109601

Haifa

3339419

Haifa

4937211

Petah Tikva

4941492

Petah Tikva

5262000

Ramat Gan

5262100

Ramat Gan

6093000

Beer Yaacov

6423906

Tel Aviv

8410101

Beersheba

9112001

Jerusalem

All Listed Sponsors

lead

Hoffmann-La Roche

INDUSTRY

NCT01988012 - A Study of the Efficacy and Safety of Tocilizumab in Adults With Rheumatoid Arthritis. | Biotech Hunter | Biotech Hunter